COX-2 inhibition and colorectal cancer
- 1 April 2004
- journal article
- review article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 31, 12-21
- https://doi.org/10.1053/j.seminoncol.2004.03.041
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout miceNature Medicine, 2001
- Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growthGastroenterology, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJama-Journal Of The American Medical Association, 2000
- Host cyclooxygenase-2 modulates carcinoma growthJCI Insight, 2000
- The Role of COX‐2 in Intestinal CancerAnnals of the New York Academy of Sciences, 1999
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.JCI Insight, 1997
- NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTIONGastroenterology Clinics of North America, 1996
- Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 1996
- Sulindac for polyposis of the colonThe American Journal of Surgery, 1989